Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karen Apelskog-Torres"'
Autor:
Stanley Fahn, Michelle Gilmor, Pauline Carter, Barbara Hubbard, David Alexoff, Payton King, Lisa Muench, Colleen Shea, Karen Apelskog-Torres, Elena Shumay, Millard Jayne, Fred McCall-Perez, Jean Logan, Frank Telang, Gene-Jack Wang, Nora D. Volkow, Joanna S. Fowler, Youwen Xu
Publikováno v:
Neuropsychopharmacology
Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson's disease. However, controlled studies have demonstrated antidepressant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795fa52021b720ae23c278ba6f790b7a
http://europepmc.org/articles/PMC4289953
http://europepmc.org/articles/PMC4289953
Autor:
Millard Jayne, Payton King, Elena Shumay, Barry Scott Brand, Daniel Burch, Wei Zhu, Karen Apelskog-Torres, Scott Carter, Robert M. Fielding, Youwen Xu, Michael J. Schueller, David Alexoff, Gene-Jack Wang, Colleen Shea, James Cecil Free, Amy K Poshusta, Pauline Carter, Joanna S. Fowler, Barbara Hubbard, Frank Telang, Jean Logan, Donald Warner, Mahnaz Asgharnejad, Lisa Muench, Albert J. Azzaro
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 35(3)
Reversible inhibitors of monoamine oxidase-A (RIMA) inhibit the breakdown of three major neurotransmitters, serotonin, norepinephrine and dopamine, offering a multi-neurotransmitter strategy for the treatment of depression. CX157 (3-fluoro-7-(2,2,2-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::402e102d2b98772defd0d28f7ebd41a7
https://pubmed.ncbi.nlm.nih.gov/19890267
https://pubmed.ncbi.nlm.nih.gov/19890267
Autor:
Lisa Muench, Jacob M. Hooker, Christopher Wong, Payton King, Gene-Jack Wang, Karen Apelskog-Torres, Nora D. Volkow, Joanna S. Fowler, Millard Jayne, David Alexoff, Donald Warner, Youwen Xu, Frank Telang, Wei Zhu, Colleen Shea, Pauline Carter, Barbara Hubbard, Jean Logan
Publikováno v:
JAMA. 301(11)
Modafinil, a wake-promoting drug used to treat narcolepsy, is increasingly being used as a cognitive enhancer. Although initially launched as distinct from stimulants that increase extracellular dopamine by targeting dopamine transporters, recent pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca9f9d521bb64428fdb30be0d5171b86
https://pubmed.ncbi.nlm.nih.gov/19293415
https://pubmed.ncbi.nlm.nih.gov/19293415